Delivery Order SPE2DB22D2211-SPE2DB25FSCKS
Award Date 8/7/25
Potential Completion Date 8/28/25
Potential Value $8.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $8,123.96 to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg capsules (21-count package) on August 1, 2025, with an ultimate completion date of August 22, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Ibrance 125 mg capsules (21-count packages) under a firm fixed-price contract valued at $8,118.08, with completion scheduled for August 22, 2025. This non-set-aside, competitively awarded delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical vendor within the DLA's medical supply chain. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ibrance 75 mg capsules (21-count packages) with a ceiling value of $8,123.96. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,122.48 for the supply of Ibrance 100 mg tablets (7-day supply) under a firm fixed price contract. The award was made on August 5, 2025, with an ultimate completion date of August 26, 2025. This is an unset-aside, competitively awarded delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $16,244.96 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg capsules (21-count) on August 5, 2025, with an ultimate completion date of August 26, 2025. This firm fixed price, non-set-aside contract reflects a routine pharmaceutical procurement to support federal medical supply needs. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order valued at $8,122.48 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg tablets (quantity 7) on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the prime contractor, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ibrance is a prescription oncology medication used...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of pharmaceutical products, specifically the drug Ibrance 125 mg capsules. The $7,792.08 firm fixed-price contract has an ultimate completion date of September 24, 2024. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the federal government, supporting various defense and civilian agencies through numerous contract vehicles. This award is likely...
- The Defense Logistics Agency awarded a $7,490.17 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 21 capsules of the pharmaceutical IBRANCE 75 MG. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance is September 6 through September 27, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this delivery order supports DLA's mission to provide critical...
- The Defense Logistics Agency Troop Support Medical awarded a $15,000 firm fixed price delivery order to Amerisourcebergen Drug Corp for 21 capsules of the drug IBRANCE 125 MG. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is from August 29, 2023 through September 20, 2023. This delivery order was awarded under the Amerisourcebergen Corporation indefinite-delivery/indefinite-quantity contract vehicle, which...
- This delivery order, awarded July 30, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides for the supply of Ibrance 75 mg tablets in quantities of seven tablets per unit. The contract, valued at $64,987.24 with a firm fixed price structure, is scheduled for completion by August 20, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside...